Libtayo flop







As long as anything is tied to Sanofi it will fail. Dupixent is unique as it sells itself and Sanofi was ties in with a great deal of money from the start. Regeneron would exit the partnership in a second if it wouldn't cost them a fortune. Outside of this partnership Sanofi is a curse to be involved with.